Quick Answer
DNA X, Inc. reported Long-Term Debt of $66.0 thousand for fiscal year 2021.
DNA X, Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2021 | $66.0K | -64.3% |
| 2020 | $185.0K | -48.9% |
| 2019 | $362.0K | -97.3% |
| 2018 | $13.21M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2022 | $37.0K | -50.0% | +23.3% |
| March 31, 2022 | $30.0K | -79.7% | -54.5% |
| December 31, 2021 | $66.0K | -64.3% | -10.8% |
| September 30, 2021 | $74.0K | -66.7% | -33.3% |
| June 30, 2021 | $111.0K | -65.8% | -25.0% |
| March 31, 2021 | $148.0K | -54.5% | -20.0% |
| December 31, 2020 | $185.0K | -48.9% | -16.7% |
| September 30, 2020 | $222.0K | -97.7% | -31.7% |
- DNA X, Inc. showed a decrease of -64.3% in Long-Term Debt compared to the prior fiscal year.
- Over the 2018–2021 period, DNA X, Inc.’s long-term debt has declined by 99.5% (from $13.21 million to $66.0 thousand).
- The most recent figure is from DNA X, Inc.’s fiscal year 2021 report (Form 10-K), filed with the SEC on March 21, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: